Liwen Zhou

3PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 16, 2026
Author Correction: Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

|May 29, 2025
ASB7 is a negative regulator of H3K9me3 homeostasis.

Liwen Zhou, Zhenxuan Chen, Yezi Zou

|Mar 09, 2023
Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity.

Yuanzhong Wu, Liwen Zhou, Yezi Zou

Pageof 1

Frequent Collaborators

3 joint publications

Yuanzhong Wu

3 joint publications

Tiebang Kang

2 joint publications

Penghui Zhou

2 joint publications

Limin Zheng